Abstract
Carbonic anhydrase inhibitors have an established place in the treatment of glaucoma. This role is based on over three decades of research on the anatomy and physiology of aqueous humor secretion, as well as the pharmacology and distribution of the sulfonamide carbonic anhydrase inhibitors in the eye.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alward PD, Wilensky JT (1981) Determination of acetazolamide compliance in patients with glaucoma. Arch Ophthalmol 99:1973–1976
Azuma I (1960) Studies on the mechanism of intraocular pressure lowering effect of acetazolamide (Diamox). Folia Ophthalmol Jpn 11:65–77
Azuma I (1973) Graphical expression of the intraocular pressure dynamics. Jpn J Ophthalmol 17:310–322
Bayne WF, Tao FT, Rogers G, Chu LC, Theeuwes F (1981) Time course and disposition of methazolamide in human plasma and red blood cells. J Pharm Sci 70:75–81
Beasley FJ (1962) Transient myopia and retinal edema during ethoxzolamide (Cardrase) therapy. Arch Ophthalmol 68:490–491
Becker B (1954) Diamox and the therapy of glaucoma. Am J Ophthalmol 38:16–17
Becker B (1955 a) The mechanism of the fall in intraocular pressure induced by the carbonic anhydrase inhibitor, Diamox. Am J Ophthalmol 39:177–184
Becker B (1955 b) The effects of the carbonic anhydrase inhibitor, acetazolamide, on the composition of aqueous humor. Am J Ophthalmol 40:129–136
Becker B (1956) The effects of acetazolamide on ascorbic acid turnover. An application of the theory of aqueous humor dynamics. Am J Ophthalmol 41:522–529
Becker B (1957) The chemical composition of human aqueous humor, effects of acetazolamide. Arch Ophthalmol 57:793–800
Becker B (1959) Carbonic anhydrase and the formation of aqueous humor. The Friedenwald memorial lecture. Am J Ophthalmol 47:342–361
Becker P (1960) Use of methazolamide (Neptazane) in the therapy of glaucoma: comparison with acetazolamide (Diamox). Am J Ophthalmol 49:1307–1311
Becker B (1961) Iodide transport by the rabbit eye. Am J Physiol 200:804–806
Becker B (1962) The measurement of aqueous flow with iodide. Invest Ophthalmol 1:52–58
Becker B, Constant MA (1955) Experimental tonography. The effect of the carbonic anhydrase inhibitor acetazolamide on aqueous flow. Arch Opthalmol 54:321–329
Benedikt O, Zirm M, Harnoncourt K (1974) Die Beziehungen zwischen metabolischer Azidose und intraokulärem Druck nach Carboanhydrasehemmung mit Acetazolamid. Albrecht Von Graefes Arch Klin Exp Ophthalmol 190:247–255
Berson FG, Epstein DL (1981) Separate and combined effects of timolol maleate and acetazolamide in open-angle glaucoma. Am J Ophthalmol 92:788–791
Berson FG, Epstein DL, Grant WM, Hutchinson BT, Dobbs P (1980) Acetazolamide dosage forms in the treatment of glaucoma. Arch Ophthalmol 98:1051–1054
Beyer KH, Baer JE (1961) Physiological basis for the action of newer diuretic agents. Pharm Rev 13:517–562
Bietti G, Virno M, Pecon-Geraldi J, Pellegrino N (1975) Acetazolamide, metabolic acidosis, and intraocular pressure. Am J Ophthalmol 80:360–369
Bill A (1975) Blood circulation and fluid dynamics in the eye. Physiol Rev 55:383–417
Birzis L, Carter CH, Maren TH (1958) Effect of acetazolamide on CSF pressure and electrolytes in hydrocephalus. Neurology 8:522–528
Block ER, Rostand RA (1978) Carbonic anhydrase inhibition in glaucoma: hazard or benefit for the chronic lunger? Surv Ophthalmol 23:169–172
Cole DF (1966) Aqueous humor formation. Doc Ophthalmol 21:116–238
Cole DF (1979) Ciliary processes. In: Heilman K, Richardson KT (eds) Glaucoma — conceptions of a disease. Saunders, Philadelphia, pp 44–53
Constant MA (1962) The distribution of 5,5-dimethyl-2,4-oxazolidinedione (DMO). II. Studies of the effect of carbonic anhydrase inhibitors and of plasma levels. Invest Ophthalmol 1:609–617
Constant MA, Becker B (1960) The effect of carbonic anhydrase inhibitors on urinary excretion of citrate by humans. Am J Ophthalmol 49:929–934
Constant MA, Falch J (1963) Phosphate and protein concentrations of intraocular fluids. I. Effect of carbonic anhydrase inhibition in young and old rabbits. Invest Ophthalmol 2:332–343
Cotlier E (1979) Bicarbonate ATP-ase in ciliary body and a theory of Diamox effect on aqueous humor formation. Int Ophthalmol 1:123–128
Crawford MA, Milne MD, Scribner BH (1959) The effects of changes in acid base balance on urinary citrate in the rat. J Physiol (Lond) 149:413–423
Dahlen K, Epstein DL, Grant WM, Hutchinson BT, Prien EL, Krall JM (1978) A repeated dose-response study of methazolamide in glaucoma. Arch Ophthalmol 96:2214–2218
Dailey RA, Brubaker RF, Bourne WM (1982) The effects of timolol maleate and acetazolamide on the rate of aqueous formation in normal human subjects. Am J Ophthalmol 93:232–237
Davenport HW (1945) The inhibition of carbonic anhydrase by thiophene-2-sulfonamide and sulfanilamide. J Biol Chem 158:567–571
Davies DW (1959) Acetazolamide with renal complications. Brit Med J 1:214–215
Davies RE (1951) The mechanism of hydrochloric acid production by the stomach. Biol Rev 26:87–120
Davson H (1969) The intraocular fluids. In: Davson H (ed) The eye, Voll, 2nd edn, Academic, New York
Draeger J, Grüttner R, Theilmann W (1963) Avoidance of side-reactions and loss of drug efficacy during long-term administration of carbonic anhydrase inhibitors by concomitant supplemental electrolyte administration. Br J Ophthalmol 47:457–468
Ellis PP (1973) Urinary calculi with methazolamide therapy. Doc Ophthalmol 34:137–142
Ellison AC, Maren TH (1972) The effects of metabolic alterations on teratogenesis. Johns Hopkins Med J 130:87–94
Epstein DL, Grant WM (1977) Carbonic anhydrase inhibitor side effects: serum chemical analysis. Arch Ophthalmol 95:1378–1382
Epstein DL, Grant WM (1979) Management of carbonic anhydrase inhibitor side effects. In: Leopold IH, Burns RP (eds) Symposium on ocular therapy, vol. 2 Wiley, New York, pp 51–64
Evans BM, Macpherson CR (1956) Some observations on acetazolamide induced nephro-calcinosis in the rat. Br J Exp Pathol 37:533–540
Forbes M, Becker B (1961) The transport of organic anions by the rabbit ciliary body. Am J Ophthalmol 51:1047–1051
Foss RH (1955) Local application of Diamox. An experimental study of its effect on the intraocular pressure. Am J Ophthalmol 39:336–339
Friedenwald JS (1949) The formation of the intra-ocular fluid. Am J Ophthalmol 32:9–27
Friedenwald JS (1955 a) Carbonic anhydrase inhibition and aqueous flow. Am J Ophthalmol 39:59–64
Friedenwald JS (1955 b) Current studies on acetazolamide (Diamox) and aqueous humor flow. Am J Ophthalmol 40:139–146
Friedland BR, Maren TH (1981) The relation between carbonic anhydrase activity and ion transport in elasmobranch and rabbit lens. Exp Eye Res 33:545–561
Friedland BR, Mallonee J, Anderson DR (1977) Short-term dose response characteristics of acetazolamide in man. Arch Ophthalmol 95:1809–1812
Friedman Z, Krupin T, Becker B (1982) Ocular and systemic effects of acetazolamide in nephrectomized rabbits. Invest Ophthalmol 23:209–213
Galin MA, Baras I, Zweifach P (1962) Diamox-induced myopia. Am J Ophthalmol 54:237–243
Garg LC, Oppelt WW (1970) The effect of ouabain and acetazolamide on the transport of sodium and chloride from plasma to aqueous humor. J Pharmacol Exp Ther 175:237–247
Garner LL, Carl EF, Ferwerda JR (1963) Advantages of sustained release therapy with acetazolamide in glaucoma. Am J Ophthalmol 55:323–327
Garrison L, Roth A, Rundle H, Christensen RE (1967) A clinical comparison of three carbonic anhydrase inhibitors. Trans Pac Coast Otolaryngol Ophthalmol Soc 48:137–145
Gelatt KN, Gum GG, Williams LW, Gwin RM (1979) Ocular hypotensive effects of carbonic anhydrase inhibitors in normotensive and glaucomatous beagles. Am J Vet Res 40:334–345
Gill WB, Vermeulen (1962) Causation of stone by two co-acting agents — Diamox and operative insult upon urinary tract. J Urol 88:103–109
Gordon EE, Sheps SG (1957) Effect of acetazolamide on citrate excretion and formation of renal calculi. Report of a case and study of five normal subjects. N Engl J Med 256:1215–1219
Grant WM (1973) Antiglaucoma drugs. Problems with carbonic anhydrase inhibitors. In: Leopold IH (ed) Symposium on ocular therapy, vol 6 Mosby, St. Louis, pp 19–38
Green H, Leopold IH (1955) Effects of locally administered Diamox. Am J Ophthalmol 40:137–139
Györy AZ, Edwards KDG, Robinson J, Palmer AA (1970) The relative importance of urinary pH and urinary content of citrate, magnesium, and calcium in the production of nephro calcinosis by diet and acetazolamide in the rat. Clin Sci 39:605–623
Hallesy DW, Layton WM (1969) Forelimb deformity of rats given dichlorphenamide during pregnancy. Proc Soc Exp Biol Med 126:6–8
Hanley T, Platts MM (1956) Diminishing effect of carbonic anhydrase inhibitor acetazolamide on urinary bicarbonate excretion. J Appl Physiol 9:279–286
Harrison HE, Harrison HC (1955) Inhibition of urine citrate excretion and the production of renal calcinosis in the rat by acetazolamide (Diamox) administration. J Clin Invest 34:1662–1670
Hodler J, Heinemann HO, Fishman AP, Smith HW (1955) Urine pH and carbonic anhydrase activity in the marine dogfish. Am J Physiol 183:155–162
Holder L, Hayes S (1965) Diffusion of sulfonamides in aqueous buffers and into red cells. Mol Pharmacol 1:266–279
Holm O, Wiebert O (1968) The effect of systemically given acetazolamide (Diamox) on the formation of aqueous humor in the human eye measured with a new photogrammetric method. Acta Ophthalmol (Copenh) 46:1243–1246
Jones RF, Maurice DM (1966) New methods of measuring the rate of aqueous flow in man with fluorescein. Exp Eye Res 5:208–220
Kass MA, Kolker AE, Gordon M, Goldberg I, Gieser DK, Krupin T, Becker B (1981) Acetazolamide and urolithiasis. Ophthalmology 88:261–265
Kimura R (1978) Effect of long-term subconjunctival administration of Diamox (acetazolamide) on the ocular tension in rabbit. Albrecht Von Graefes Arch Klin Exp Ophthalmol 205:221–227
Kinsey VE (1953) Comparative chemistry of aqueous humor in posterior and anterior chambers of rabbit eyes. Arch Ophthalmol 50:401–417
Kinsey VE (1971) Ion movement in ciliary processes. In: Bittar EE (ed) Membranes and ion transport, vol. 3. Wiley, New York, pp 185–209
Kinsey VE, Reddy DVN (1959) Turnover of carbon dioxide in the aqueous humor and the effect thereon of acetazolamide. AMA Arch Ophthalmol 62:78–83
Kinsey VE, Camacho E, Cavanaugh GA, Constant MA (1955 a) Diamox and intraocular fluid dynamics. Am J Opthalmol 40:147–148 (abstract)
Kinsey VE, Camacho E, Cavanaugh GA, Constant MA, McGinty DA (1955 b) Dependence of IOP-lowering effect of acetazolamide on salt. Arch Ophthal 53:680–685
Kinsey VE, Reddy DVN, Skrentny BA (1960) Intraocular transport of 14C-labelled urea and the influences of Diamox on its rate of accumulation in aqueous humors. Am J Ophthalmol 50:1130–1141
Kolker AE, Hetherington J (1976) Medications that decrease the rate of aqueous formation. In: Becker-Shaffer’s diagnosis and therapy of the glaucomas, 4th edn. Mosby, St. Louis, pp 336–353
Kristinnson A (1967) Fatal reaction to acetazolamide. Br J Ophthalmol 51:348–349
Krupin T, Oestrich CJ, Bass J, Podos SM, Becker B (1977) Acidosis, alkalosis, and aqueous humor dynamics in rabbits. Invest Ophthalmol 16:997–1101
Kupfer C, Gaasterland D, Ross K (1971) Studies of aqueous humor dynamics in man. II. Measurements in young normal subjects using acetazolamide and L-epinephrine. Invest Ophthalmol 10:523–533
Landes RR (1976) Incidence and management of ureteral calculi in general hospital patients: a nationwide survey. In: Finlayson B, Thomas WC (eds) Colloquium on renal lithiasis. University Presses of Florida, Gainesville, pp 249–276
Langham ME, Lee PM (1957) Action of Diamox and ammonium chloride on the formation of aqueous humor. Br J Ophthalmol 41:65–92
Langlois (1966) Diamox et thrombocytopénie. Arch Ophthal (Paris) 26:701–705
Layton WM, Hallesy DW (1965) Deformity of forelimb in rats: association with high doses of acetazolamide. Science 149:306–308
Lehmann B, Linner E, Wistrand PJ (1969) The pharmacokinetics of acetazolamide in relation to its use in the treatment of glaucoma and its effects as an inhibitor of carbonic anhydrases. In: Rospe G (ed) Schering workshop in pharmakokinetics, advances in the biosciences 5. Pergamon, New York, pp 197–217
Leopold IH, Eisenberg IJ, Yasuma J (1955) Experience with Diamox in glaucoma. Am J Ophthalmol 39:885–888
Lichter PR, Newman LP, Wheeler NC, Beall OV (1978) Patient tolerance to carbonic anhydrase inhibitors. Am J Ophthalmol 85:495–502
Linner E (1956) Further studies of the episcleral venous pressure in glaucoma. Am J Ophthalmol 41:646–651
Linner E (1978) Ocular hypertension. II. A carbonic anhydrase test for early detection of glaucoma. Acta Ophthalmol 56:179–189
Linner E, Friedenwald TS (1957) The appearance time of fluorescein as an index of aqueous flow. Am J Ophthalmol 44:225–229
Macdonald MJ, Crane SM, Cullen PM, Phillips CI (1977) Comparison of ocular hypotensive effects of acetazolamide and atenolol. Br J Opthalmol 61:345–348
Mackenzie AR (1960) Acetazolamide induced renal stone. J Urol 84:453–455
Macri FJ, Dixon RL, Rall DP (1965) Aqueous humor turnover rates in the cat. I. Effect of acetazolamide. Invest Ophthalmol 4:927–934
Mann T, Keilin D (1940) Sulfanilamide as a specific inhibitor of carbonic anhydrase. Nature 146:164–165
Maren TH (1956) Carbonic anhydrase inhibition. IV. The effects of metabolic acidosis on the response to Diamox. Bull Johns Hopkins Hosp 98:159–183
Maren TH (1963 a) The relation between enzyme inhibition and physiological response in the carbonic anhydrase system. J Pharmacol Exptl Therap 139:140–153
Maren TH (1963 b) Ionic composition of cerebrospinal fluid and aqueous humor of the dogfish, Squalus acanthias. Comp Biochem Physiol 5:201–215
Maren TH (1967) Carbonic anhydrase: chemistry, physiology, and inhibition. Physiol Rev 47:595–781
Maren TH (1968) Renal carbonic anhydrase and the pharmacology of sulfonamide inhibitors. In: Herken H (ed) Diuretica. Springer, Berlin Heidelberg New York, pp 195–256 (Handbook of experimental pharmacology, vol. 24)
Maren TH (1971) Teratology and carbonic anhydrase inhibition. Arch Ophthalmol 85:1–2
Maren TH (1974 a) Chemistry of the renal reabsorption of bicarbonate. Can J Physiol Pharmacol 52:1041–1050
Maren TH (1974 b) \({\rm{HCO}}_3^ -\) formation in aqueous humor: mechanism and relation to the treatment of glaucoma. Invest Ophthalmol 13:479–484
Maren TH (1976 a) The rates of movement of Na+, CI−, and \({\rm{HCO}}_3^ -\) from plasma to posterior chamber: effect of acetazolamide and relation to the treatment of glaucoma. Invest Ophthalmol 13:356–364
Maren TH (1976 b) Relations between structure and biological activity of sulfonamides. Annu Rev Pharmacol Toxicol 16:309–327
Maren TH (1977 a) Physiology and chemistry of cerebrospinal fluid, aqueous humor and endolymph in Squalus acanthias. J Exp Zool 199:317–324
Maren TH (1977 b) Ion secretion into the posterior aqueous humor of dogs and monkeys. Exp Eye Res [Suppl] 25:245–247
Maren TH (1979) Theodore Weicker Oration: An historical account of CO2 chemistry and the development of carbonic anhydrase inhibitors. Pharmacologist 20:303–321
Maren TH (1980) Cerebrospinal fluid, aqueous humor, and endolymph. In: Mountcastle VB (ed) Medical physiology, 14th edn. Mosby, St. Louis, pp 1218–1252
Maren TH, Ellison AC (1972) The teratological effect of certain thiadiazoles related to acetazolamide, with a note on sulfanilamide and thiazide diuretics. Johns Hopkins Med J 130:95–104
Maren TH, Robinson B (1960) The pharmacology of acetazolamide as related to cerebrospinal fluid and the treatment of hydrocephalus. Bull Johns Hopkins Hosp 106:1–24
Maren TH, Wiley CE (1968) The in vitro activity of sulfonamides against red cell carbonic anhydrases. J Med Chem 11:228–232
Maren TH, Mayer E, Wadsworth BC (1954 a) Carbonic anhydrase inhibition. I. The pharmacology of Diamox, 2-acetylamino-l,3,4-thiadiazole 5-sulfonamide. Bull Johns Hopkins Hosp 95:199–243
Maren TH, Wadsworth BC, Yale EK, Alonso, LG (1954 b) Carbonic anhydrase inhibition. III. Effects of Diamox on electrolyte metabolism. Bull Johns Hopkins Hosp 95:277–321
Maren TH, Wistrand P, Swenson ER, Talalay AR (1975) The rates of ion movement from plasma to aqueous humor in the dogfish, Squalus acanthias. Invest Ophthalmol 14:662–673
Maren TH, Haywood JR, Chapman SK, Zimmerman TJ (1977) The pharmacology of methazolamide in relation to the treatment of glaucoma. Invest Ophthalmol 16:730–742
Maren TH, Friedland BR, Rittmaster R (1980) Kinetic properties of primitive vertebrate carbonic anhydrases. Comp Biochem Physiol 67B:69–74
Maren TH, Jankowska L, Sanyal G, Edelhauser HF (1983) The transcameral permeability of sulfonamide carbonic anhydrase inhibitors and their effect on aqueous humor secretion. Exp Eye Res 36:457–480
Meldrum NU, Roughton FJW (1933) Carbonic anhydrase: its preparation and properties. J Physiol (Lond) 80:113–142
Merkle W (1980) Untersuchungen über die Wirkung von Methazolamid auf den intraokulären Druck. Klin Monatsbl Augenheilkd 176:181–185
Merté HJ, Heilman K, Hallwich I (1977) Untersuchungen über die Wirkung von verschiedenen Dosierungen von Acetazolamid (Diamox) auf den intraokolären Druck. Klin Monatsbl Augenheilkd 170:473–479
Miller JE (1962) Alterations of the blood-aqueous potentials in the rabbit. Invest Ophthalmol 1:59–62
Moses RA (1980) Intraocular pressure. In: Moses RA (ed) Adler’s physiology of the eye, 7th edn. Mosby, St. Louis, Chap. 8, p 227
Nissen OI, Kjer D, Olsen L (1976) A comparison between an acetazolamide test and weight tonography in pathological and apathological circulation of the aqueous humor. Invest Ophthalmol 15:844–848
Oppelt WW (1967) Measurement of aqueous humor formation rates by posterior-anterior chamber perfusion with inulin. Normal values and the effect of carbonic anhydrase inhibition. Invest Ophthalmol 6:76–88
Owen EE, Tyor MP, Flanagan JF, Berry JN (1960) The kidney as a source of blood ammonia in patients with liver disease: the effect of acetazolamide. J Clin Invest 39:288–294
Parfitt AM (1969) Acetazolamide and sodium bicarbonate induced nephrocalcinosis and nephrothiasis, relationship to citrate and calcium excretion. Arch Int Med 24:736–740
Pepys MB (1970) Acetazolamide and renal stone formation. Lancet 1:837
Persky L, Chambers D, Potts A (1956) Calculus formation and ureteral colic following acetazolamide (Diamox) therapy. JAMA 161:1625–1626
Petounis AD, Chandreli S, Vaulaluka-Sekioti A (1980) Effect of hypercapnea on human intraocular pressure during general anesthesia following acetazolamide administration. Br J Ophthalmol 64:422–425
Rector FC (1981) Acid-base renal physiology. In: Brenner BM, Rector FC (eds) The kidney, 2nd edn. Saunders, Philadelphia, pp 286–298
Rentiers PK, Johnson AC, Buskard N (1970) Severe aplastic anemia as a complication of acetazolamide therapy. Can J Ophthalmol 5:337–342
Roblin RO Jr, Clapp JW (1950) The preparation of heterocyclic sulfonamides. J AM Chem Soc 72:4890–4892
Roughton FJW (1935) Recent work on carbon dioxide transport by the blood. Physiol Rev 15:241–296
Rubenstein MA, Bucy JG (1975) Acetazolamide-induced renal calculi. J Urol 114:610–612
Scharrer A, Ober M (1979) Timolol and acetazolamide in the treatment of increased intraocular presure. Albrecht Von Graefes Arch Klin Exp Ophthalmol 212:129–134
Shah A, Constant MA, Becker B (1958) Urinary excretion of citrate in humans following administration of acetazolamide (Diamox). Arch Ophthalmol 59:536–540
Shields MB, Simmons RJ (1976) Urinary calculus during methazolamide therapy. Am J Ophthalmol 81:622–624
Söser M, Ogriseg M, Kessler B, Zirm H (1980) New findings concerning changes in intraocular pressure and blood acidosis after peroral application of acetazolamide. Klin Monatsbl Augenheilkd 176:88–92
Southworth H (1937) Acidosis associated with the administration of para-amino-benzene sulfonamide (Prontylin). Proc Soc Exp Biol Med 36:58–61
Spaeth GL (1967) Potassium, acetazolamide, and intraocular pressure. Arch Ophthalmol 78:578–582
Stanescu B, Michiels J (1975) The effects of acetazolamide on the human electroretinogram. Invest Ophthalmol 14:935–937
Stein A, Pinke R, Krupin T, Glabb E, Podos SM, Serle J, Maren TH (1983) The effect of topically administered carbonic anhydrase inhibitors on aqueous humor dynamics in rabbits. Am J Ophthalmol 95:222–228
Stiegier G (1979) Bupranolol eyedrops in glaucoma therapy. Klin Monatsbl Augenheilkd 174:267–275
Stone RA, Zimmerman TJ, Shin DH, Becker B, Kass MA (1977) Low-dose methazolamide and intraocular pressure. Am J Ophthalmol 83:674–679
Swenson ER, Maren TH (1978) A quantitative analysis of CO2 transport at rest and during maximal exercise. Respir Physiol 35:129–159
Takemoto M (1978) Prophylaxis for acetazolamide induced urolithiasis: clinical study. Jpn J Urol 69:963–987
Vaziri ND, Saiki J, Barton CH, Rajudin M, Ness R (1980) Hemodialyzability of acetazolamide. South Med J 73:422–423
Wallace TR, Fraunfelder FT, Petursson GJ, Epstein DC (1979) Decreased libido — a side effect of carbonic anhydrase inhibitor. Ann Ophthalmol 11:1563–1566
Weiner IM, Washington TA, Mudge GH (1959) Studies on the renal excretion of salicylate in the dog. Bull Johns Hopkins Hosp 105:284–297
Weiss IS (1974) Hirsutism after chronic administration of acetazolamide. Am J Ophthalmol 78:327–331
Werblin TP, Pollack IP, Liss RA (1979) Aplastic anemia and agranulocytosis in patients using methazolamide for glaucoma. JAMA 241:2817–2818
Wisch N, Fischbein FI, Siegel R, Glass JL, Leopold I (1973) Aplastic anemia resulting from the use of carbonic anhydrase inhibitors. Am J Ophthalmol 75:130–132
Wistrand PJ (1951) Carbonic anhydrase in the anterior uvea of the rabbit. Acta Physiol Scand 24:144–148
Wistrand PJ (1957) Local action of the carbonic anhydrase inhibitor, acetazolamide, on the intraocular pressure in cats. Arch Pharmacol Toxicol 14:27–37
Wistrand PJ (1959) The effect of carbonic anhydrase inhibitor on intra-ocular pressure with observations on the pharmacology of acetazolamide in the rabbit. Acta Pharmacol Toxicol 16:171–193
Wistrand PJ (1964) Intraocular pressure and resistance to aqueous outflow. Effects of carbonic anhydrase inhibition, salt depletion, adrenalectomy and fluoro-cortisone. Exp Eye Res 3:141–155
Wistrand P (1974) Pharmacokinetics and pharmacodynamics of acetazolamide in relation to its use in the treatment of glaucoma. In: Teorell T, Dedrick RL, Condliffe PG (eds) Pharmacology and pharmacokinetics. Plenum, New York, pp 191–194
Wistrand PJ, Garg LC (1979) Evidence of a high activity C type of carbonic anhydrase in human ciliary processes. Invest Ophthalmol 18:802–806
Wistrand PJ, Maren TH (1960) The effect of carbonic anhydrase on intraocular pressure of rabbits with different blood CO2 equilibria. Am J Ophthalmol 50:291–297
Wistrand PJ, Nechay BR, Maren TH (1960 a) Effect of carbonic anhydrase inhibition on cerebrospinal and intraocular fluids in the dog. Acta Pharmacol Toxicol 17:315–336
Wistrand PJ, Rawls JA, Maren TH (1960 b) Sulfonamide carbonic anhydrase inhibitors and intra-ocular pressure in rabbits. Acta Pharmacol Toxicol 17:337–355
Yakatan GJ, Frome EL, Leonhard RG, Shah AC, Doluisio JT (1978) Bioavailability of acetazolamide tablets. J Pharm Sci 67:252–256
Yonemura D, Kawasaki K (1979) New approaches to ophthalmic electrodiagnosis by retinal oscillatory potential, drug induced responses from retinal pigment epithelium and cone potential. Doc Ophthalmol 48:163–222
Zimmerman TJ, Garg LC, Vogh BP, Maren TH (1976 a) The effect of acetazolamide on the movement of anions into the posterior chamber of the dog eye. J Pharmacol Exp Therap 196:510–515
Zimmerman TJ, Garg LC, Vogh BP, Maren TH (1976 b) The effect of acetazolamide on the movement of sodium into the posterior chamber of the dog eye. J Pharmacol Exp Therap 199:510–517
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Friedland, B.R., Maren, T.H. (1984). Carbonic Anhydrase: Pharmacology of Inhibitors and Treatment of Glaucoma. In: Sears, M.L. (eds) Pharmacology of the Eye. Handbook of Experimental Pharmacology, vol 69. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69222-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-69222-2_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69224-6
Online ISBN: 978-3-642-69222-2
eBook Packages: Springer Book Archive